Chronic Kidney Disease Market to Reach $24.8B by 2026

Strategic Insights -

The Chronic Kidney Disease market is expected to reach $24.8 billion by 2026, growing at a CAGR of 6.6% during the forecast period. The market is driven by the increasing incidence of chronic kidney diseases, technological advancements in diagnostic tests, and the rising need for early detection. The North America region is expected to hold the largest market share due to developed healthcare infrastructure and government initiatives offering lucrative reimbursement policies.

Key Takeaways:

  • The global prevalence of end-stage renal diseases (ESRD) is high and increasing at a significant rate, with around 850 million people worldwide suffering from kidney disorders.
  • The blood test segment by diagnosis is expected to witness high growth over the forecast period, driven by the increasing incidence of CKD and the need for early detection.
  • The market in the United States is expected to grow due to the rapid increase in the incidence and prevalence of kidney diseases, with an estimated 73,750 new cases of kidney cancer in 2020 and 14,830 deaths from this disease.
  • Key market players include Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, and GlaxoSmithKline Plc, with companies focusing on the launch of new products in the market.
  • The market is driven by the increasing incidence of chronic kidney diseases, technological advancements in diagnostic tests, and the rising need for early detection, with the market expected to reach $24.8 billion by 2026.

Statistics:

  • The global prevalence of end-stage renal diseases (ESRD) is high and increasing at a significant rate (World Kidney Day, 2020).
  • Around 850 million people worldwide suffer from kidney disorders (World Kidney Day, 2020).
  • The market is expected to grow at a CAGR of 6.6% from 2021 to 2026.
  • The market is expected to reach $24.8 billion by 2026.
  • The lifetime risk for developing kidney cancer in men is about 1 in 46 (2.02%), and the lifetime risk for women is about 1 in 82 (1.02%) (American Cancer Society, 2020).
  • In 2020, there would be around 73,750 new cases of kidney cancer in the United States and approximately 14,830 deaths from this disease (American Cancer Society, 2020).

Sources:

  • World Kidney Day (2020)
  • International Journal of Nephrology (2018)
  • American Cancer Society (2020)
  • ResearchAndMarkets.com (2022)
  • International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF)